Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. DWTX
DWTX logo

DWTX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dogwood Therapeutics Inc (DWTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.060
1 Day change
52 Week Range
9.500
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Dogwood Therapeutics Inc (DWTX) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock lacks clear positive catalysts, shows weak financial performance, and has no significant trading signals or analyst ratings to support a bullish stance. Given the neutral technical indicators and the absence of recent news or influential trading activity, it is advisable to hold off on investing in this stock until more favorable conditions arise.

Technical Analysis

The MACD is positive and expanding, indicating a potential bullish trend. However, the RSI is neutral at 54.371, and moving averages are converging, suggesting no strong momentum. Key support and resistance levels are at S1: 2.777 and R1: 3.351, with the stock currently trading near the pivot point at 3.064.

Positive Catalysts

  • NULL identified. No recent news or significant trading activity from insiders, hedge funds, or Congress.

Neutral/Negative Catalysts

  • Weak financial performance in Q3 2025, with revenue at 0 and a significant net income loss of -15.74M. EPS dropped by 84.03% YoY, indicating poor profitability. Stock trend analysis suggests a potential decline of -3.93% in the next day, -4.39% in the next week, and -8.28% in the next month.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth YoY. Net income improved by 590.35% YoY but remains negative at -15.74M. EPS dropped significantly by 84.03% YoY to -8.2, reflecting poor earnings performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available.

Wall Street analysts forecast DWTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast DWTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.060
sliders
Low
12
Averages
21
High
30
Current: 3.060
sliders
Low
12
Averages
21
High
30
H.C. Wainwright
H.C. Wainwright
Buy
maintain
$10 -> $12
AI Analysis
2025-09-30
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$10 -> $12
AI Analysis
2025-09-30
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Dogwood to $12 from $10 and keeps a Buy rating on the shares after the company announced a new licensing agreement with Serpin Pharma.
HC Wainwright & Co.
Sean Lee
Hold
to
Strong Buy
Upgrades
$10
2025-04-23
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$10
2025-04-23
Upgrades
Hold
to
Strong Buy
Reason

People Also Watch